Article

ARVO 2023: No evidence linking dietary vitamin intake and attenuation of dry eye disease

Author(s):

Instead, vitamins C and E may actually be associated with a slightly increased risk of DED.

an image of a bottle of vitamins spilled out with pills coming out of it. (Image Credit: AdobeStock/New Africa)

(Image Credit: AdobeStock/New Africa)

Dietary vitamin intake is not associated with attenuated dry eye disease (DED), according to a recent study reported at the Association of Research in Vision and Ophthalmology annual meeting.

Interestingly, first author Long Nguyen, MD, MS, from the Department of Plastic and Reconstructive Surgery, Oslo Universitetssykehus, Norway reported instead that vitamins C and E may actually be associated with a slightly increased risk of DED.

The rationale for the study was that adequate vitamin intake is considered essential for ocular health and is thought to also play a role in DED.

The investigators conducted a large population-based, cross-sectional study to attempt to clarify the association between dietary vitamin intake and the risk of DED.

The 51,551 study participants (mean age, 51.2 years; 60% women) were from the population-based Lifelines cohort. DED was assessed via the Women’s Health Study dry eye questionnaire, which defines DED 2 ways: either based on a previous DED diagnosis established by a clinician or based on highly symptomatic dry eye (“often” or “constant” symptoms of both dryness and irritation of the eyes), the authors described.

The authors assessed the total daily intake of vitamins A, B2, B6, B12, C, and E from food and drinks (excluding supplements) using the Food Frequency Questionnaires.

The analysis of the relationship between DED and vitamin intake with adjustment for demographics, body mass index, smoking status, vitamin supplement use, and 48 comorbidities.

They also investigated an association between DED and meeting the recommended daily intake of vitamins, based on the NIH recommendations. In addition, the authors repeated the analyses separately in participants who did not use vitamin supplements to remove the possible impact associated with supplement use.

Results of the DED analysis

DED based on the definition used in the Women’s Health Study was present in 9.1% of the population.

The authors reported, “Higher intakes of vitamin C and vitamin E increased the odds for having DED.” In addition, the participants who satisfied the recommended intake of vitamins C and E, had increased odds of developed DED, ie, 14% and 10%, respectively, compared with participants who did not satisfy the recommended intake of those vitamins.

The intake levels of vitamins A, B2, B6, and B12 were not significantly associated with a risk of developing DED. In subjects who did not use vitamin supplements, the associations were similar to those seen in the total population.

The investigators concluded, “This large population-based study found no evidence that dietary vitamin intakes attenuated the risk of DED. Instead, vitamin C and, to a lesser extent, vitamin E, may be associated with a slightly increased risk of DED. The causes for the direction of this association should be explored further as it went against our hypothesis and previous findings.”

Related Videos
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.